ANTIPHOSPHOLIPID SYNDROME
Clinical trials for ANTIPHOSPHOLIPID SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTIPHOSPHOLIPID SYNDROME trials appear
Sign up with your email to follow new studies for ANTIPHOSPHOLIPID SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aimed at preventing clots in rare autoimmune disease
Disease control TerminatedThis study was designed to test if crovalimab, added to standard blood thinners, could prevent dangerous blood clots in people with antiphospholipid syndrome (APS), a condition that increases clot risk. It was a Phase 2 trial for adults aged 18-70 with a history of multiple clots…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 05:25 UTC
-
Pregnancy study for rare diseases cancelled before it began
Knowledge-focused TerminatedThis study planned to follow women with rare autoimmune diseases (like lupus or arthritis) through pregnancy to learn about complications and improve care. It was withdrawn before any participants enrolled, so no results are available. The goal was to gather information to help d…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 26, 2026 05:25 UTC